0001354457-11-000214.txt : 20111006
0001354457-11-000214.hdr.sgml : 20111006
20111006155435
ACCESSION NUMBER: 0001354457-11-000214
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20111006
DATE AS OF CHANGE: 20111006
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Jiangbo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001091164
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651130026
STATE OF INCORPORATION: FL
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34763
BUSINESS ADDRESS:
STREET 1: MIDDLE SECTION, LONGMAO STREET, AREA A
STREET 2: LAIYANG WAIXIANGXING INDUSTRIAL PARK
CITY: LAIYANG CITY, YANTAI, SHANDONG
STATE: F4
ZIP: 710075
BUSINESS PHONE: 5619889880
MAIL ADDRESS:
STREET 1: MIDDLE SECTION, LONGMAO STREET, AREA A
STREET 2: LAIYANG WAIXIANGXING INDUSTRIAL PARK
CITY: LAIYANG CITY, YANTAI, SHANDONG
STATE: F4
ZIP: 710075
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Pharmaceuticals Enterprises, Inc.
DATE OF NAME CHANGE: 20071108
FORMER COMPANY:
FORMER CONFORMED NAME: GENESIS TECHNOLOGY GROUP INC
DATE OF NAME CHANGE: 20020516
FORMER COMPANY:
FORMER CONFORMED NAME: NEWAGECITIES COM INC
DATE OF NAME CHANGE: 19990719
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NASDAQ Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: 9600 BLACKWELL RD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
25-NSE
1
primary_doc.xml
X0203
0001354457
NASDAQ Stock Market LLC
0001091164
Jiangbo Pharmaceuticals, Inc.
001-34763
25 Haibe Road
Laiyang Economic Development Zone
Laiyang City, Shandong Prov.
F4
CHINA
561 988-9880
Common Stock
17 CFR 240.12d2-2(b)
Amy Horton
Associate General Counsel
2011-10-06
EX-99.25
2
jgbodelistreason.txt
Delisting Determination,The Nasdaq Stock Market, LLC,
October 6, 2011, Jiangbo Pharmaceuticals, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Jiangbo Pharmaceuticals, Inc.
(the Company), effective at the opening of the
trading session on October 17, 2011. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5101, 5605(c)(3), IM-5605,
and 5605(c)(2)(A). The Company was notified of the
Staffs determination on July 26, 2011. The Company
did not appeal the Staff determination to the Hearings
Panel. The Companys shares were suspended and the Staff
determination to delist the Company
became final on August 4, 2011.